Cigna is a national commercial insurer with broadly typical PA practices for GLP-1 medications.
Generally covered for T2D. Typical copay $25–$100/month with PA.
Variable. Cigna commercial plans cover Wegovy and Zepbound for weight indication with PA; some employer-elected plans exclude weight management.
Coverage under March 2024 Wegovy CV indication expanding.
Coverage of Zepbound for OSA expanding.
Typical PA criteria: BMI thresholds; documented lifestyle modification 3–6 months; comorbidity documentation.
Verify with your specific plan; cash-pay compounded as alternative if PA fails.
The most reliable way to verify coverage is to call the member services number on your insurance card and ask: (1) Is [Wegovy/Zepbound/Ozempic/Mounjaro] on my formulary? (2) What tier? (3) What are the prior authorization criteria? (4) What's my expected copay at each tier? Document the date, the rep's name, and any reference number.
If insurance coverage is unworkable, see our price index for current cash-pay compounded options. Our editor's pick, NexLife, runs $145–$215/month flat-rate.